Skip to content

Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study

Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02714387
Acronym
ATLANREA
Enrollment
5000
Registered
2016-03-21
Start date
2013-02-28
Completion date
2050-01-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Traumatic Acute Brain Injury

Keywords

Non traumatic acute brain injury

Brief summary

The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.

Detailed description

Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.

Interventions

A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Non Traumatic Neuro-Vascular Diseases

Exclusion criteria

* Consent withdrawal

Design outcomes

Primary

MeasureTime frameDescription
in ICU stay complicationsWithin the first 28 days after ICU admission dateHospital acquired infections (epidemiology, risk factors, antibiotic susceptibility of pathogens), Organ failures (incidence, risks factors), Bleeding, Hemorrhage Intra-Cranial Hypertension, Brain Ischemia, Mechanical ventilation weaning, Extubation failure

Secondary

MeasureTime frame
Duration in mechanical ventilationin ICU (up to 90 days)
ICU length of stayin ICU (up to 90 days)

Other

MeasureTime frame
Deathin ICU (up to 180 days)

Countries

France

Contacts

Primary ContactKarim Asehnoune, PhD, MD
karim.asehnoune@chu-nantes.fr02 40 08 73 80
Backup ContactAntoine Roquilly, MD
antoine.roquilly@chu-nantes.fr02 40 08 73 80

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026